Hot Topics

News

Convalescent Plasma Therapy for COVID-19 Patients

Experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection is the focus of a new two-part research initiative.

Read more
News

CRISPR-engineered T cells in Patients with Refractory Cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published in Science by researchers from the Abramson Cancer Center.

Read more
publication

CRISPR-engineered T cells in patients with refractory cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center.

Read more
publication

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia

An image from this article is featured on the cover of this edition of Blood Advances, a semimonthly medical journal published by the American Society of Hematology.  The cover figure of&

Read more
News

Penn's Gene Therapy Startup Raises Another $50 Million

Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.

Read more
News

National Blood Foundation Early-Career Grant for Dr. Vijay Bhoj

Award for research in the fields of transfusion medicine and cellular therapies.

Read more